# US 2021/0010052 A1 · Marker and method for determination of parkinson's disease

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2021/0010052 A1
- Document ID: US20210010052A1
- Status: Published application
- Kind: A1
- Application number: 16/612,968
- Filed: 2018-05-17
- Published: 2021-01-14
- Earliest claimed: 2017-05-18
- Assignees: Kabushiki Kaisha Yakult Honsha; National University Corporation Nagoya University
- Applicants: Kabushiki Kaisha Yakult Honsha; National University Corporation Nagoya University
- Inventors: Hirokazu TSUJI; Takashi ASAHARA; Koji NOMOTO; Masaaki HIRAYAMA; Kinji OHNO
- Web page: https://patentgrep.com/patent/US20210010052A1

## CPC

- C12Q 1/06: Quantitative determination
- C12Q 1/10: Enterobacteria
- C12N 1/20: Bacteria; Culture media therefor
- C12Q 1/689: for bacteria
- G01N 33/56916: {Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia}
- G01N 33/68: involving proteins, peptides or amino acids {(involving lipoproteins G01N33/92)}
- G01N 33/6896: {Neurological disorders, e.g. Alzheimer's disease}
- G01N 33/92: involving lipids, e.g. cholesterol {, lipoproteins, or their receptors (steroid hormones G01N33/743)}
- C12Q 1/6851: Quantitative amplification
- C12R 2001/24: Lactobacillus brevis
- C12R 2001/25: Lactobacillus plantarum
- G01N 2333/24: from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- G01N 2333/335: from Lactobacillus (G)
- G01N 2400/50: Lipopolysaccharides; LPS
- G01N 2800/2835: Movement disorders, e.g. Parkinson, Huntington, Tourette
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C12R: INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS

## Abstract

The present invention relates to a method for simply diagnosing the progress of disease condition of a Parkinson's disease patient. Provided are a method for determining Parkinson's disease using the number of one or more intestinal bacteria selected from the group consisting of Bifidobacterium, Bacteroides fragilis group, Lactobacillus brevis, and Lactobacillus plantarum subgroup and/or the total number of intestinal bacteria as a marker, and a method for determining Parkinson's disease using the blood LPS level and/or the blood LBP level of a Parkinson's disease patient as an indicator.

## Claims

### Claim 1

A marker for detecting Parkinson's disease, the marker being the number of one or more intestinal bacteria selected from the group consisting of Bifidobacterium, Bacteroides fragilis group, Lactobacillus brevis, and Lactobacillus plantarum subgroup and/or the total number of intestinal bacteria.

### Claim 2 (depends on 1)

The marker according to claim 1, wherein the detecting of Parkinson's disease is detecting a risk of deterioration of Parkinson's disease.

### Claim 3 (depends on 2)

The marker according to claim 2, wherein the deterioration of Parkinson's disease is deterioration of a constipation symptom or a psychiatric symptom.

### Claim 4 (depends on 3)

The marker according to claim 3, wherein the psychiatric symptom is one or more selected from the group consisting of hallucination, cognition, and motivation.

### Claim 5

A method for detecting deterioration of a disease condition of a Parkinson's disease patient, comprising measuring the numbers of one or more intestinal bacteria selected from the group consisting of Bifidobacterium, Bacteroides fragilis group, Lactobacillus brevis, and Lactobacillus plantarum subgroup and/or the total numbers of intestinal bacteria in the patient at two or more different time points and comparing the numbers.

### Claim 6 (depends on 5)

The method according to claim 5, wherein the deterioration of a disease condition of a Parkinson's disease patient is deterioration of a constipation symptom or a psychiatric symptom.

### Claim 7 (depends on 6)

The method according to claim 6, wherein the psychiatric symptom is one or more selected from the group consisting of hallucination, cognition, and motivation.

### Claim 8

A marker for detecting Parkinson's disease, the marker being a blood LPS level and/or a blood LBP level.

### Claim 9 (depends on 8)

The marker according to claim 8, wherein the detecting of Parkinson's disease is detecting a risk of deterioration of Parkinson's disease.

### Claim 10 (depends on 9)

The marker according to claim 9, wherein the deterioration of Parkinson's disease is deterioration of a constipation symptom or a psychiatric symptom.

### Claim 11 (depends on 10)

The marker according to claim 10, wherein the psychiatric symptom is one or more selected from the group consisting of hallucination, cognition, and motivation.

### Claim 12

A method for detecting deterioration of a disease condition of a Parkinson's disease patient, comprising measuring blood LPS levels and/or blood LBP levels of the patient at two or more different time points and comparing the levels.

### Claim 13 (depends on 12)

The method according to claim 12, wherein the deterioration of a disease condition of a Parkinson's disease patient is deterioration of a constipation symptom or a psychiatric symptom.

### Claim 14 (depends on 13)

The method according to claim 13, wherein the psychiatric symptom is one or more selected from the group consisting of hallucination, cognition, and motivation.

### Claim 15 (depends on 5)

A kit for conducting the method according to claim 5, the kit comprising a protocol for measuring the intestinal bacteria.
